Pharmac funds second-line treatment for macular degeneration

+News

Pharmac funds second-line treatment for macular degeneration

NZD

New Zealand Doctor Rata Aotearoa

Eylea
Pharmac will subsidise Eylea at $1250 per 40mg vial pack
Pharmac has funded a drug that will broaden treatment options for macular degeneration sufferers who find existing treatment ineffective.  Afliberc